Literature DB >> 9188064

Computational sequence analysis of the tissue inhibitor of metalloproteinase family.

D A Douglas1, Y E Shi, Q A Sang.   

Abstract

The tissue inhibitor of metalloproteinase (TIMP) family regulates extracellular matrix turnover and tissue remodeling by forming tight-binding inhibitory complexes with matrix metalloproteinases (MMPs). MMPs and TIMPs have been implicated in many normal and pathological processes, such as morphogenesis, development, angiogenesis, and cancer metastasis. This minireview provides information that would aid in classification of the TIMP family and in understanding the similarities and differences among TIMP members according to the physical data, primary structure, and homology values. Calculations of molecular weight, isoelectric point values, and molar extinction coefficients are reported. This study also compares sequence similarities and differences among the TIMP members through calculations of homology within their individual loop regions and the mature region of the molecule. Lastly, this report examines structure-function relationships of TIMPs. Thorough knowledge of TIMP primary and tertiary structure would facilitate the uncovering of the molecular mechanisms underlying metalloproteinase, inhibitory activities and biological functions of TIMPs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188064     DOI: 10.1023/a:1026348808069

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  85 in total

Review 1.  The matrix-degrading metalloproteinases.

Authors:  L M Matrisian
Journal:  Bioessays       Date:  1992-07       Impact factor: 4.345

2.  The role of the C-terminal domain in collagenase and stromelysin specificity.

Authors:  G Murphy; J A Allan; F Willenbrock; M I Cockett; J P O'Connell; A J Docherty
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

3.  Differential screening of ovarian cDNA libraries detected the expression of the porcine collagenase inhibitor gene in functional corpora lutea.

Authors:  T Tanaka; N Andoh; T Takeya; E Sato
Journal:  Mol Cell Endocrinol       Date:  1992-01       Impact factor: 4.102

Review 4.  The matrix metalloproteinases and their inhibitors.

Authors:  G Murphy; A J Docherty
Journal:  Am J Respir Cell Mol Biol       Date:  1992-08       Impact factor: 6.914

5.  Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2.

Authors:  E W Howard; E C Bullen; M J Banda
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

6.  Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2.

Authors:  S Shimizu; K Malik; H Sejima; J Kishi; T Hayakawa; O Koiwai
Journal:  Gene       Date:  1992-05-15       Impact factor: 3.688

7.  A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family.

Authors:  N Pavloff; P W Staskus; N S Kishnani; S P Hawkes
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

8.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity.

Authors:  W G Stetler-Stevenson; N Bersch; D W Golde
Journal:  FEBS Lett       Date:  1992-01-20       Impact factor: 4.124

9.  Site-directed mutations that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13.

Authors:  M O'Shea; F Willenbrock; R A Williamson; M I Cockett; R B Freedman; J J Reynolds; A J Docherty; G Murphy
Journal:  Biochemistry       Date:  1992-10-27       Impact factor: 3.162

10.  The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

Authors:  G Murphy; F Willenbrock; R V Ward; M I Cockett; D Eaton; A J Docherty
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

View more
  17 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

3.  Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.

Authors:  Mohammed A Majid; Valerie A Smith; Andrew C Newby; Andrew D Dick
Journal:  Br J Ophthalmol       Date:  2007-03-23       Impact factor: 4.638

Review 4.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  Naringin inhibits the invasion and migration of human glioblastoma cell via downregulation of MMP-2 and MMP-9 expression and inactivation of p38 signaling pathway.

Authors:  Sonia Aroui; Feten Najlaoui; Yassine Chtourou; Annie-Claire Meunier; Amel Laajimi; Abderraouf Kenani; Hamadi Fetoui
Journal:  Tumour Biol       Date:  2015-10-16

Review 6.  Matrix metalloproteinases in tumorigenesis: an evolving paradigm.

Authors:  Hui Hua; Minjing Li; Ting Luo; Yancun Yin; Yangfu Jiang
Journal:  Cell Mol Life Sci       Date:  2011-07-10       Impact factor: 9.261

Review 7.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 8.  Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.

Authors:  Francis G Spinale; Francisco Villarreal
Journal:  Biochem Pharmacol       Date:  2014-04-26       Impact factor: 5.858

9.  Matrix metalloproteinases and their inhibitors in gastric cancer.

Authors:  G I Murray; M E Duncan; E Arbuckle; W T Melvin; J E Fothergill
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

10.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.